drugset / Trial / NCT07212803

Effects of Energy Drinks on Cardiovascular Endpoints

NCT07212803

Phase 4 Recruiting 3 enrolled University of the Pacific
RandomizedCrossoverQuadruple-blindOther

Summary

This is a clinical trial looking at the impact of energy drinks on heart related parameters. The study will enroll 3 participants who will be exposed to 8 different interventions.

Timeline

Start
2025-11-01
Primary completion
2026-03
Completion
2026-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Moxifloxacin Small molecule 400 mg Oral

Indications

No indication recorded.